Helge Rørvik Røsjø

Image of Helge Rørvik Røsjø
Norwegian version of this page
Username
Visiting address Sykehusveien 25 1474 Nordbyhagen
Postal address Akershus universitetssykehus 1478 Lørenskog

Research interests

Cardiovascular biomarkers

Heart failure

Intelligent health

Pragmatic trials

Precision medicine

Translational cardiovascular research

Education

2012   Philosophiae Doctor (PhD), Faculty of Medicine, University of Oslo, Norway

2003   Medical Doctor (MD), Faculty of Medicine, University of Oslo, Norway  

Academic positions

2018-           Head of Research and Innovation, Akershus University Hospital

2017-2019   Cardiology fellow and post-doctoral fellow, University Hospital Uppsala and Uppsala Clinical Research Center, Uppsala, Sweden

2016-2017    50% residency (Medicine), Division of Medicine, Akershus University Hospital, Lørenskog, Norway- Nephrology and Endocrinology

2013-2018    Head of Research, Division of Medicine, Akershus University Hospital

2020-            Professor II, University of Oslo

2013-2020    Associate Professor, University of Oslo

2011-2013    Head of Clinical Trial Unit, Division of Medicine, Akershus University Hospital

2009-2011    Research scientist/PrincipaI Investigator Akershus Cardiac Examination #1-3 Studies

2006-2009    Research fellow, University of Oslo, Oslo, Norway

2005-2006    Residency (Medicine), Division of Medicine, Akershus University Hospital, Lørenskog, Norway

Collaboration

Bærum Hospital, Vestre Viken Hospital Trust Gjettum Norway, Akershus Cardiac Examination

CardiNor AS

Spinchip

Supervision

Main Supervisor,  6 PhD students, Faculty of Medicine, University of Oslo:

Co-Supervisor, 6 PhD students, Faculty of Medicine, University of Oslo

Medical student compulsory thesis, 3 medical students, Faculty of Medicine, University of Oslo

Publications

View all works in Cristin

  • Axfors, Cathrine; Schmitt, Andreas M.; Janiaud, Perrine; van’t Hooft, Janneke; Abd-Elsalam, Sherief & Abdo, Ehab F. [Show all 94 contributors for this article] (2024). Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z). Nature Communications. ISSN 2041-1723. 15(1). doi: 10.1038/s41467-024-45360-6.
  • Sæther, Julie Caroline; Follestad, Turid; Klevjer, Marie; Giskeødegård, Guro F.; Bathen, Tone Frost & Gigante, Bruna [Show all 10 contributors for this article] (2023). Circulating lipoprotein subfractions and microRNAs as potential biomarkers for improved risk prediction of myocardial infarction: the HUNT study.
  • Sourour, Nur; Riveland, Egil Aarstad; Omland, Torbjørn; Kjekshus, Harald; Larsen, Alf Inge & Røsjø, Helge Rørvik [Show all 7 contributors for this article] (2023). Re: Detailed association between B-type natriuretic peptide levels and ventricular tachyarrhythmia. Clinical Cardiology. ISSN 0160-9289. 46(12), p. 1604–1605. doi: 10.1002/clc.24145. Full text in Research Archive
  • Lundin, Knut Erik Aslaksen; Røsjø, Helge Rørvik; Myhren, Hilde; Kvale, Dag & Rosvold, Elin Olaug (2021). Legeutdanning i en pandemitid. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 141. doi: 10.4045/tidsskr.21.0581.
  • Berge, Kristian; Lyngbakken, Magnus Nakrem; Omland, Torbjørn; Juliebø, Vibeke; Schirmer, Henrik & Røsjø, Helge Rørvik (2021). Ytterligere læringsmomenter fra et kardiologisk perspektiv. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 141(1). doi: 10.4045/tidsskr.20.1025.
  • Myhre, Peder Langeland; Lyngbakken, Magnus Nakrem; Røsjø, Helge Rørvik & Omland, Torbjørn (2020). Removing stable and adding precision to chronic coronary artery disease. International Journal of Cardiology. ISSN 0167-5273. 316, p. 54–56. doi: 10.1016/j.ijcard.2020.04.063.
  • Tveit, Sjur Hansen; Myhre, Peder Langeland; Røsjø, Helge Rørvik & Omland, Torbjørn (2020). Reply: The complementary role of cardiac troponin I and cardiac troponin T. Clinical Biochemistry. ISSN 0009-9120. 78. doi: 10.1016/j.clinbiochem.2020.02.011.
  • Lyngbakken, Magnus; Berdal, Jan Erik; Eskesen, Arne N; Kvale, Dag; Inge Christoffer, Olsen & Rangberg, Anbjørg [Show all 10 contributors for this article] (2020). Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Trials. ISSN 1745-6215. 21. doi: 10.1186/s13063-020-04420-0.
  • Tveit, Sjur Hansen; Myhre, Peder Langeland; Le, Tri Minh; Seljeflot, Ingebjørg; Høiseth, Arne Didrik & Røsjø, Helge [Show all 7 contributors for this article] (2019). Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study. Clinical Biochemistry. ISSN 0009-9120. doi: 10.1016/j.clinbiochem.2019.12.016.
  • Aarsetøy, Reidun; Omland, Torbjørn; Røsjø, Helge; Strand, Heidi; Aarsetøy, Hildegunn & Staines, Harry [Show all 7 contributors for this article] (2019). N-terminal Pro-B-Type Natriuretic Peptide may serve as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest, whereas both high-sensitivity cardiac troponin-T and copeptin did not yield prognostic information. Circulation 2019; 140: Suppl 2, Abstract 135 .
  • Røsjø, Helge Rørvik; Caironi, Pietro; Meessen, Jennifer; Latini, Roberto & Omland, Torbjørn (2018). The authors reply. Critical Care Medicine. ISSN 0090-3493. 46(9), p. E959–E961. doi: 10.1097/CCM.0000000000003248.
  • Ottesen, Anett Hellebø; Carlson, Cathrine Rein; Laver, Derek R; Myhre, Peder Langeland; Dalhus, Bjørn & Lunde, Per Kristian [Show all 14 contributors for this article] (2017). Secretoneurin is an Endogenous CaMKII Inhibitor That Attenuates Ca2+-Dependent Arrhythmogenesis. Circulation. ISSN 0009-7322. 136.
  • Lyngbakken, Magnus Nakrem; Røsjø, Helge; Holmen, Oddgeir Lingaas; Dalen, Håvard; Hveem, Kristian & Omland, Torbjørn (2017). Temporal Changes in Cardiac Troponin I and Risk of Cardiovascular Events in the General Population: The Nord-Trøndelag Health Study.
  • Myhre, Peder Langeland & Røsjø, Helge (2017). Cardiovascular biomarkers. Universitetet i Oslo. ISSN 9788283770339.
  • Ottesen, Anett Hellebø & Røsjø, Helge (2017). Functional aspects of granin proteins in Cardiac disease. Universitetet i Oslo. ISSN 9788283333916.

View all works in Cristin

Published Aug. 27, 2012 8:30 PM - Last modified Mar. 15, 2024 12:23 PM